Please login to the form below

Not currently logged in
Email:
Password:

Aerie Pharmaceuticals appoints new members of its commercialisation team

David Biddell, Shaun Gentry and Erin Horn join the firm

Eye-disease focused pharmaceutical company Aerie Pharmaceuticals has appointed a trio of new comers to its commercialisation team.

David Biddell joins the US group as its regional sales director for the southeast region, reporting to Gary Menichini who is currently vice president of sales.

Meanwhile, Shaun Gentry and Erin Horn both join from Novartis as directors of national accounts in the market access group.

They will both report to Dale Seibt, who is vice president of market access for North Carolina-based Aerie.

28th November 2017

From: Sales

Share

Tags

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
IPG Health Medical Communications

We are the world's most celebrated and awarded Medical Communications agencies. We are 800 experts obsessed with combining science, creativity...

Latest intelligence

Mainimage2
The role of digital health technology tools in supporting medical adherence
How DHT-based digital interventions can help to support patients and improve adherence...
How To Tell A Better Silent Story
They say a picture's worth 1,000 words, which is incredibly helpful when telling a silent story....
Main image1
Global leaders in digital channels
Exploring why UK field teams are global leaders in digital channels is key to better understanding the changes in omnichannel engagement...